About tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)
tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene) (PubChem CID 159258297) has the molecular formula C154H135F3N40Pt5
and a molecular weight of 3578.44 g/mol. Its IUPAC name is tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene).
Analyze tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene) with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)?
The IUPAC name of tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene) (CID 159258297) is tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene).
What is the SMILES notation for tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)?
The canonical SMILES for tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene) is CC(C)(C)c1n[n-]c(-c2ncnc3ccccc23)c1C(F)(F)F.CC12CCC(c3c1n[n-]c3-c1ncnc3ccccc13)C2(C)C.CC12CCC(c3c1n[n-]c3-c1ncnc3ccccc13)C2(C)C.Cc1c(C(C)(C)C)n[n-]c1-c1ncnc2ccccc12.Cc1c(C(C)(C)C)n[n-]c1-c1ncnc2ccccc12.Cc1c(C(C)(C)C)n[n-]c1-c1ncnc2ccccc12.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1ccc2c(-c3[n-]nc4ccccc34)ncnc2c1.c1ccc2c(-c3[n-]nc4ccccc34)ncnc2c1.c1ccc2c(-c3ccncn3)[n-]nc2c1.c1ccc2c(-c3ccncn3)[n-]nc2c1.
What is the InChIKey of tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)?
The InChIKey is KWEKXTBUWSWOTK-UHFFFAOYSA-N. The full InChI is InChI=1S/2C19H19N4.C16H14F3N4.3C16H17N4.2C15H9N4.2C11H7N4.5Pt/c2*1-18(2)12-8-9-19(18,3)17-14(12)16(22-23-17)15-11-6-4-5-7-13(11)20-10-21-15;1-15(2,3)14-11(16(17,18)19)13(22-23-14)12-9-6-4-5-7-10(9)20-8-21-12;3*1-10-13(19-20-15(10)16(2,3)4)14-11-7-5-6-8-12(11)17-9-18-14;2*1-3-7-12-10(5-1)14(17-9-16-12)15-11-6-2-4-8-13(11)18-19-15;2*1-2-4-9-8(3-1)11(15-14-9)10-5-6-12-7-13-10;;;;;/h2*4-7,10,12H,8-9H2,1-3H3;4-8H,1-3H3;3*5-9H,1-4H3;2*1-9H;2*1-7H;;;;;/q10*-1;5*+2.
What are the key properties of tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)?
tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene) has a molecular weight of 3578.44 g/mol, XLogP of 30.27, 10 rotatable bonds, 0 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for tris(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);4-[3-tert-butyl-4-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(4-indazol-2-id-3-ylquinazoline);pentakis(platinum(2+));bis(3-pyrimidin-4-ylindazol-2-ide);bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene) is sourced from PubChem (CID 159258297), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).